Market Outlook:

The anticipated global allergy diagnostic market size is poised to reach USD 5.3 Billion by 2024, with a projected escalation to USD 11.3 Billion by 2032, reflecting a compound annual growth rate (CAGR) of 11.45% during the forecast period (2025-2032). 

An allergy turns into medical symptoms when a person touches or consumes certain substances and breathes particular particles. The immune system creates bodily responses whenever it finds external triggers such as pollen, food, pets, bee venom, and other substances. A person who is allergic usually develops symptoms like skin hives, body rashes, stomach pains, blocked/runny nose, nasal irritations, and red eye swelling. Food items that assist allergic people manage their condition are fatty fish, yogurt, tropical fruits, local honey, and onions. For allergies, antihistamines work best. Determine-allergy tools and techniques make it possible to locate specific allergy triggers as they help identify if someone matches an allergic disease pattern. Excessive allergy symptoms trouble millions of people worldwide and can progress from minor to life-threatening anaphylaxis. Doctors need to identify conditions correctly at once to start useful medical help right away.

Market Dynamics:

Driver:

The growing use of in vitro diagnostic techniques boosts the growth of the allergy diagnostics market. In vitro diagnostic tests are rising due to the growing chronic diseases, as well as the need for early, precise diagnosis and personal medical care. Several types of continuing health conditions, including diabetes, heart disease, and cancer, now affect people all across the world more than ever. Healthcare systems place early disease detection as their priority, as in vitro diagnostic testing effectively supports this goal. Current medical technology, like next-generation sequencing and artificial intelligence-based diagnostic tools, has greatly improved in vitro diagnostic performance and accuracy. The FDA has approved several next-generation sequencing in vitro diagnostics in recent years, which shows that precision medicine demands continue to drive their popularity. Officials in authorized U.S. and European Union agencies have adopted new in vitro diagnostic strategies that back their growing importance in today's medical environment.

Restraint:

The high cost of allergy diagnostic procedures hampers the growth of the allergy diagnostics market. High costs for allergy testing limited its use throughout medical facilities. Diagnostic technology equipment like immunoassay analyzers and skin testers, along with allergy test supplies, make up allergy testing procedures. The selected elements give precise and reliable results for diagnosis. The monetary worth of every item mentioned makes it cost-prohibitive for broad testing adoption. Providers pay both to install new technology initially and later to keep it running, plus buy necessary supplies.

Opportunity:

The increasing technological advancements and increasing demand for at-home diagnostic solutions create a lucrative opportunity for the growth of the allergy diagnostics market. People can now detect their allergies by using simple home test kits that help them test themselves at home. The companies Everlywell and Immuven produce basic tests for common allergens such as food sensitivity, pollens, and cat dander at low prices. Home allergy test kits made the science accessible for many populations, including areas without standard medical facilities. National allergy diagnostics sales have the potential for growth from using AI and machine learning technology. Artificial intelligence systems help medical tests achieve better results, which in turn speed up the delivery of accurate diagnoses. Personalized medicine's success requires better allergy testing technology, which creates high market demand. The allergy diagnostic industry has good potential to grow as people need more precise treatments.

Challenge:

Differing test results represent the main problem area. Normal diagnostic exams often show inaccurate results that can result in the wrong identification of allergies and improper therapy planning. Skin prick test mistakes can prevent healthy adults from handling allergens, and doctors could miss severe allergic conditions because of faulty test reading results. New technology validation and receiving approvals from medical authorities like the FDA and EMA takes a lengthy administrative process. The need for regulatory approvals slows down market entry for new products because of related safety risks. Several countries maintain different healthcare processes, so allergy testing standards remain hard to unite.

Key Players:

• Thermo Fisher Scientific
• Siemens
• Danaher Corporation 
• Omega Diagnostics Group PLC 
• Minaris Medical America, Inc. 
• Stallergenes Greer 
• HOB Biotech Group Corp., Ltd.
• HYCOR Biomedical
• Lincoln Diagnostics, Inc.
• INDOOR Biotechnologies, Inc. 
• Dr. Fooke Laboratorien GmbH
• R-Biopharm AG
• GA Generic Assays GmbH 
• Tecan Trading AG 
• DST Diagnostische Systeme & Technologien GmbH
• Others

Recent Development:

• In August 2023, Danaher Corporation added new allergen components to its ImmunoCAP® allergy test menu to provide more individualized allergy care. 

• In June 2023, Omega Diagnostics Group PLC's VISITECT® Rapid Soya ELISA test for detecting soy allergies was CE-marked.

Segment Insights:

By Test Type

The in-vitro test segments hold the largest position in the allergy diagnostics market. The test checks for specific immunoglobulin E reactions against particular allergens. Researchers noticed that measuring Serum IgE gives high accuracy in detecting reactions to airborne allergens. Medical experts worldwide see food allergy as a major public health concern that is rising in all developed and developing nations. This increasing trend will boost the market for allergy diagnostics over the forecast period. Statistical data from Food Allergy Research and Education shows that around 2.8 million Americans had an egg allergy in 2020, as 2.5 million people had a wheat allergy in the same year.

By Allergen

The market breaks down its products into categories of inhaled allergens, food allergens, drug allergens, and others. In 2023, the market for inhaled allergens held the strongest position. The inhaled allergens department leads market growth over the forecast period at a quick rate. The major share of this market segment results from rising air pollution and increased urban life issues that make people susceptible to dust mites and spores inside their homes. During 2023, Hospital-based labs and medical facilities make up most of the allergy testing market share. In 2023, the hospital's underground labs and clinics controlled the highest percentage of the total market share. The high segment value tracks from our partnership with medical experts and our ability to diagnose all conditions, plus our low pricing. 

Regional Insights:

North America is the dominating region for the allergy diagnostics market. Allergy cases are increasing throughout this area, while the government helps support specific programs. Healthcare spending in North America remains high due to its developed status as an area. U.S.-based firms put much effort into making these medications as their company understands the medical needs of many patients in their country. The main companies determined to launch their products into this market will intensify North American competitive rivalries. The Asian Pacific market will have strong commercial growth due to several important reasons. Health care infrastructure and reforms keep pushing the market ahead. The market growth relies on several important drivers, including more people on Earth and growing rates of allergies, plus local enterprises joining the market. Due to the fast growth of Asia Pacific's important markets, Japan, China, and India, they will decrease market availability throughout the region. Different companies across these markets follow different business strategies to strengthen their industry leadership. 

Segmentation:

By Product & Service

• Consumables
• Instruments
• Services

By Test Type 

• In-Vivo Tests
• In-Vitro Tests

By Allergen

• Inhaled Allergens
• Food Allergens
• Drug Allergens
• Others

By End-User

• Diagnostic Laboratories
• Hospital-Based Laboratories & Clinics
• Academic Research Institutes
• Others

By Region

North America

• USA

• Canada

• Mexico

Europe

• France

• UK

• Spain

• Germany

• Italy

• Rest of Europe

Asia Pacific

• China

• Japan

• India

• South Korea

• Rest of Asia Pacific

Middle East & Africa

• GCC

• South Africa

• Rest of the Middle East & Africa

South America

• Brazil

• Argentina

• Rest of South America

What to Expect from Industry Profile?

1. Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the Allergy Diagnostic market in the world.

2. Use PORTER’s Five Forces analysis to determine the competitive intensity and therefore market attractiveness of the Global Allergy Diagnostic market.

3. Leading company profiles reveal details of key Allergy Diagnostic market players’ global operations, strategies, financial performance & recent developments.

4. Add weight to presentations and pitches by understanding the future growth prospects of the Global Allergy Diagnostic market with a forecast for the decade by both market share (%) & revenue (USD Million).

FAQ’s

1) What are the major factors driving the growth of the Global Allergy Diagnostic Market?

• The growing use of in vitro diagnostic techniques boosts the growth of the allergy diagnostics market. 

2) What would be the CAGR of the Global Allergy Diagnostic Market over the forecast period?

• The Global Allergy Diagnostic Market is poised to grow at a CAGR of 11.45% from 2025 to 2032.

3) Which region will provide more business opportunities for the growth of the Global Allergy Diagnostic Market in the future?

• The North America region is expected to create more opportunities in the market.

4) Who are the major players dominating the Global Allergy Diagnostic Market?

• Thermo Fisher Scientific, Siemens, Danaher Corporation, Omega Diagnostics Group PLC, Minaris Medical America, Inc., Stallergenes Greer, HOB Biotech Group Corp., Ltd., HYCOR Biomedical, Lincoln Diagnostics, Inc., INDOOR Biotechnologies, Inc., Dr. Fooke Laboratorien GmbH, R-Biopharm AG, GA Generic Assays GmbH, Tecan Trading AG, DST Diagnostische Systeme & Technologien GmbH, Others.

5) What are the segments in the Global Allergy Diagnostic Market?

• By Product & Service, By Test Type, By Allergen, and By End-User are the industry key segments considered for the research study.

6) What is the estimated market revenue for the Global Allergy Diagnostic Market in 2032?

• The estimated revenue for the Global Allergy Diagnostic Market in 2032 is USD 11.3 Billion.